BWM
CELGZ

Baystate Wealth Management’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Baystate Wealth Management’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20
Closed – – 690
2019
Q3 		$0 Hold
20
– – ﹤0.01% 673
2019
Q2 		$1K Hold
20
– – ﹤0.01% 641
2019
Q1 		$1K Hold
20
– – ﹤0.01% 657
2018
Q4 		$1K Hold
20
– – ﹤0.01% 671
2018
Q3 		$1K Hold
20
– – ﹤0.01% 679
2018
Q2 		$1K Hold
20
– – ﹤0.01% 689
2018
Q1 		$1K Hold
20
– – ﹤0.01% 672
2017
Q4 		$1K Hold
20
– – ﹤0.01% 665
2017
Q3 		$1K Hold
20
– – ﹤0.01% 642
2017
Q2 		$1K Hold
20
– – ﹤0.01% 690
2017
Q1 		$1K Buy
+20
New +$22 ﹤0.01% 656

Baystate Wealth Management's CELGZ Position: Q4 2019 in Review

Baystate Wealth Management sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 20 shares.

Baystate Wealth Management first reported a position in CELGZ in Q1 2017 and held it in 11 quarters. The position peaked at $1K in Q2 2019. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.

  • Baystate Wealth Management reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • Baystate Wealth Management sold 20 Celgene Corporation Contingent Value Rights shares in Q4 2019.
  • Baystate Wealth Management first reported a position in Celgene Corporation Contingent Value Rights in Q1 2017 and held it in 11 quarters.
  • Baystate Wealth Management's Celgene Corporation Contingent Value Rights position peaked at $1K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.

Based on Baystate Wealth Management's 13F filing for Q4 2019, filed 21 Jan 2020.